Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Regan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2000
Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled caseinC C Metges, A E El-Khoury, A B Selvaraj, et al.
The American Journal of Clinical Nutrition|May 3, 2001
Lysine requirements of healthy adult Indian subjects, measured by an indicator amino acid balance techniqueA V Kurpad, T Raj, A El-Khoury, et al.
The American Journal of Clinical Nutrition|December 3, 1999
Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomatesC C Metges, K J Petzke, A E El-Khoury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2025
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancerH J Burstein, G Curigliano, M Gnant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2009
Phase II study of sunitinib in men with advanced prostate cancerM Dror Michaelson, M M Regan, W K Oh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialB Ejlertsen, J Aldridge, K V Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostateM-H Tay, D S Kaufman, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 studyS J Luen, R Asher, C K Lee, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Endocrinology and Metabolism|May 29, 2000
Kinetics of L-[1-(13)C]leucine when ingested with free amino acids, unlabeled or intrinsically labeled caseinC C Metges, A E El-Khoury, A B Selvaraj, et al.
The American Journal of Clinical Nutrition|May 3, 2001
Lysine requirements of healthy adult Indian subjects, measured by an indicator amino acid balance techniqueA V Kurpad, T Raj, A El-Khoury, et al.
The American Journal of Clinical Nutrition|December 3, 1999
Incorporation of urea and ammonia nitrogen into ileal and fecal microbial proteins and plasma free amino acids in normal men and ileostomatesC C Metges, K J Petzke, A E El-Khoury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 10, 2025
Tailoring treatment to cancer risk and patient preference: the 2025 St Gallen International Breast Cancer Consensus Statement on individualizing therapy for patients with early breast cancerH J Burstein, G Curigliano, M Gnant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2009
Phase II study of sunitinib in men with advanced prostate cancerM Dror Michaelson, M M Regan, W K Oh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2011
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trialB Ejlertsen, J Aldridge, K V Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostateM-H Tay, D S Kaufman, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancerA Ravaioli, F Monti, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 studyS J Luen, R Asher, C K Lee, et al.
Pageof 5